Drug
Astegolimab
Astegolimab: highest development phase Phase 3, developed by Roche. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Roche
Trials
| Drug | Phase | Indication |
|---|---|---|
| Astegolimab NCT05878769 | Phase 3 | Chronic Obstructive Pulmonary Disease |
Latest
No recent events.
Follow Astegolimab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.